Letter #1 Response to letter to Editor by Dr. Sarkar et al. for' who said differentiating preeclampsia from COVID-19 infection was easy? Refers to PII: S2210-7789(21)00539-0 Letter #2 Response to letter to Editor by Dr. Hantoushzadeh et al. for' is COVID-19 disease a risk factor for preeclampsia? Should aspirin be considered for prophylaxis of preeclampsia in these patients?' Refers to PII: S2210-7789(21)00538-9.

Jayaram, A; Buhimschi, I A; Buhimschi, C S

Jayaram, A; Buhimschi, I A; Buhimschi, C S.

Jayaram A; Department of Obstetrics & Gynecology, University of Illinois at Chicago College of Medicine, 820 S. Wood, St. Chicago, IL 60612, United States. Electronic address: ajayaram@uic.edu.
Buhimschi IA; Department of Obstetrics & Gynecology, University of Illinois at Chicago College of Medicine, 820 S. Wood, St. Chicago, IL 60612, United States.
Buhimschi CS; Department of Obstetrics & Gynecology, University of Illinois at Chicago College of Medicine, 820 S. Wood, St. Chicago, IL 60612, United States.

Pregnancy Hypertens ; 27: 94-95, 2022 03.

Article in English | MEDLINE | ID: covidwho-1594445

Subject(s)

COVID-19; Pre-Eclampsia; Aspirin; Humans; Pre-Eclampsia/diagnosis; Risk Factors; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pre-Eclampsia / COVID-19 Type of study: Diagnostic study / Prognostic study Limits: Humans Language: English Journal: Pregnancy Hypertens Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google